U.S. Pressure Ulcer Prevention Market Size, Wound Care Solutions and Growth Forecast 2026–2034

U.S. Pressure Ulcer Prevention Market Overview Analysis By Fortune Business Insights

Market at a Glance

According to Fortune Business Insights: The U.S. pressure ulcer prevention market was valued at USD 438.3 million in 2022 and is projected to grow at a CAGR of 4.1% during the forecast period of 2023–2030. The market's steady expansion is driven by a rapidly aging population, rising ICU admissions, and the growing number of patients receiving care in homecare settings — all of which contribute to an elevated risk of pressure ulcer development across the country.

Pressure ulcers, also known as pressure injuries or bedsores, are primarily preventable clinical conditions. Their prevention has become a central focus of healthcare facilities nationwide, as their incidence is widely regarded as a direct indicator of nursing care quality and patient safety standards.

Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/107896

Key Market Drivers

Aging population and chronic disease burden represent the foremost growth catalyst. According to the Center for Technology & Aging, eight out of ten older Americans are living with one or more chronic conditions. A study published by the National Center for Biotechnology Information (NCBI) in January 2023 projected that the number of U.S. individuals aged 50 and older with at least one chronic condition would reach 142.7 million by 2050 — a near doubling from the 71.5 million recorded in 2020. As this population expands, so does the susceptibility to immobility-related complications such as pressure ulcers.

Rising ICU admissions further amplify market demand. According to the Society of Critical Care Medicine, more than 5 million patients are admitted to U.S. intensive care units annually for acute or life-threatening conditions. Patients in critical care face the highest risk of pressure injury development due to prolonged immobility, reduced circulation, and underlying health vulnerabilities — factors that collectively drive the adoption of preventive products in hospital settings.

Growth in homecare settings is an emerging demand driver. As more patients — particularly elderly individuals — manage chronic conditions at home, the need for accessible, easy-to-use preventive devices such as foam mattresses, alternating pressure pads, and wheelchair cushions in non-institutional settings continues to rise.

Market Challenges

Low adherence to prevention guidelines is the primary restraint on market growth. Insufficient education and awareness among healthcare professionals and patient caregivers continues to limit consistent implementation of evidence-based pressure ulcer prevention protocols. According to Medscape estimates published in April 2022, the prevalence of pressure injuries in nursing homes ranges from 2.6% to 24% among patients — a wide variance that reflects inconsistent preventive practices across care settings.

The financial toll of inadequate prevention is substantial. According to the Agency for Healthcare Research and Quality (AHRQ), U.S. hospitals spend approximately USD 9.1 to 11.6 billion annually on the prevention and treatment of pressure ulcers — reinforcing the urgent need for stronger clinical adherence and investment in preventive measures.

The COVID-19 pandemic also temporarily impacted the market, as surging hospitalizations for COVID-19 patients coincided with a decline in non-COVID-19 admissions, disrupting normal procurement and adoption patterns for pressure ulcer prevention products.

Segmentation Insights

By Product Type: The market covers static support surfaces (foam mattresses, gel overlays, alternating pressure pads), dynamic support surfaces (alternating-air mattresses, low-air-loss mattresses, air-fluidized or high-air-loss mattresses), dressings, positioners and protectors, and creams and other topical solutions.

Dynamic support surfaces led the market in 2022, driven primarily by strong demand for alternating-air mattresses and air-fluidized mattresses. The comparatively accessible price points of these products relative to other advanced solutions have further supported widespread adoption across care settings. The market has also seen growing utilisation of alternating pressure pads and low-air-loss wheelchair cushions in both hospital and outpatient environments to offload pressure and promote the prevention and healing of pressure injuries.

By End User: Hospitals and ambulatory surgery centers captured the largest market share in 2022, reflecting high healthcare expenditure on pressure ulcer management and the concentration of high-risk patients in acute care environments. Long-term care and urgent care centers held the second-largest share, consistent with the CDC's finding that more than one in ten individuals with limited mobility in long-term care facilities develop pressure ulcers. Homecare settings represent a growing end-user segment as patient care increasingly shifts from institutional to home-based environments.

Connect with Our Expert for any Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/107896

Competitive Landscape

The U.S. pressure ulcer prevention market is moderately fragmented, with no single player dictating overall market direction. Leading companies include Stryker, Baxter (which reinforced its position through the December 2021 acquisition of Hill-Rom Holdings, Inc.), Medline Industries LP, Agiliti Health Inc., Invacare Corporation, Cardinal Health, Integra LifeSciences, and 3M. In October 2021, Agiliti Health further expanded its capabilities through the acquisition of Sizewise, a specialist manufacturer of hospital beds and patient-handling equipment. These players compete on the basis of product innovation, breadth of portfolio, and strategic partnerships to serve a diverse and growing patient population.

Outlook

The U.S. pressure ulcer prevention market is set for consistent growth through 2030, underpinned by demographic shifts, rising chronic disease prevalence, and increasing awareness of preventable hospital-acquired complications. Strengthening clinical education, expanding homecare product access, and advancing prevention technologies will be critical levers for both patient outcomes and market expansion in the coming years.